Alpha Tau Medical (DRTS) Cash from Investing Activities (2021 - 2022)
Alpha Tau Medical (DRTS) posted quarterly Cash from Investing Activities of -$92.4 million for Q2 2022, down 30898.99% on a QoQ basis from -$298000.0 in Q1 2022.
Alpha Tau Medical (DRTS) Cash from Investing Activities (2021 - 2022) Analysis & Trends
Alpha Tau Medical (DRTS) has reported Cash from Investing Activities for 2 consecutive years, with -$92.4 million the latest figure, recorded in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.72 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 470.64 Bn | 465.84 Bn | 1.35 Bn | -45.51 Mn |
| 5 | Vertex Pharmaceuticals | 122.91 Bn | 115.67 Bn | 2.59 Bn | -431.90 Mn |
| 6 | Regeneron Pharmaceuticals | 70.07 Bn | 61.31 Bn | 3.31 Bn | -428.90 Mn |
| 7 | Belite Bio | 62.77 Bn | 62.77 Bn | - | - |
| 8 | Argenx Se | 56.21 Bn | 51.02 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.60 Bn | 37.60 Bn | - | 172.62 Mn |
| 10 | Alpha Tau Medical | 1.11 Bn | 1.11 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -92.38 Mn |
| Jun 30, 2022 | -92.38 Mn |
| Mar 31, 2022 | -298,000.00 |
| Mar 31, 2022 | -298,000.00 |
| Mar 31, 2021 | -609,000.00 |
| Mar 31, 2021 | -609,000.00 |